4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-005107
Director acquired 2,137 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2022-01-26 | Option exercise | +803 | $2.11 | $1,694 | 86,641 | D |
| Anderson Kenneth Carl Director | 2022-01-26 | Option exercise | +1,334 | $4.98 | $6,643 | 87,975 | D |
| Derivatives | |||||||
| Anderson Kenneth Carl Director | 2022-01-26 | Option exercise · Stock Option (Right to Buy) | −803 | 2,137 | D | ||
| Anderson Kenneth Carl Director | 2022-01-26 | Option exercise · Stock Option (Right to Buy) | −1,334 | 2,668 | D | ||
Loading xslF345X03/doc4.xml…